These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23681089)

  • 21. Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases.
    Bottai V; Giannotti S; Dell'osso G; De Paola G; Menconi A; Falossi F; Raffaetà G; Guido G
    Osteoporos Int; 2014 Mar; 25(3):993-7. PubMed ID: 24173536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
    Reddy SV; Gupta SK
    Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical heterogeneity of atypical fractures during prolonged use of bisphosphonates--risk factors and bone turnover markers].
    Piazzetta G; Baracho FR; Oliveira Ld; Santos GR; Kulak CA; Borba VZ
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):855-61. PubMed ID: 25465610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical outcome of intramedullary nailing in patients with complete atypical femoral fracture: A multicenter retrospective study.
    Lee KJ; Yoo JJ; Oh KJ; Yoo JH; Rhyu KH; Nam KW; Suh DH
    Injury; 2017 Apr; 48(4):941-945. PubMed ID: 28274470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.
    Cermak K; Shumelinsky F; Alexiou J; Gebhart MJ
    Clin Orthop Relat Res; 2010 Jul; 468(7):1991-6. PubMed ID: 20020334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
    Capeci CM; Tejwani NC
    J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-traumatic Atypical Peri-implant Femoral Fracture at the Distal Screw after Short Femoral Nail Fixation for a Pertrochanteric Fracture.
    Yamamoto N; Dan'ura T; Noda T; Ozaki T
    Acta Med Okayama; 2020 Apr; 74(2):151-157. PubMed ID: 32341590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?
    Edwards MH; McCrae FC; Young-Min SA
    Osteoporos Int; 2010 Apr; 21(4):701-3. PubMed ID: 19562241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous femoral shaft fracture after long-term alendronate.
    Ali T; Jay RH
    Age Ageing; 2009 Sep; 38(5):625-6. PubMed ID: 19556326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
    Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
    Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Criteria and Treatment of Atypical Ulnar Fractures Associated With Prolonged Bisphosphonate Therapy: Multicenter Case Analysis.
    Heo YM; Park SE; Cha SM; Shin HD; Choi JK
    J Hand Surg Am; 2022 Sep; 47(9):901.e1-901.e12. PubMed ID: 34565638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
    Spinelli MS; Marini E; Daolio PA; Piccioli A
    Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
    J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
    Ng YH; Gino PD; Lingaraj K; Das De S
    Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical femoral fractures bilaterally in a patient receiving denosumab.
    Drampalos E; Skarpas G; Barbounakis N; Michos I
    Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
    [No Abstract]   [Full Text] [Related]  

  • 38. Can long-term bisphosphonate use causes low-energy fractures? A case report.
    Dandinoğlu T; Akarsu S; Karadeniz M; Tekin L; Arıbal S; Kıralp MZ
    Osteoporos Int; 2014 Feb; 25(2):773-6. PubMed ID: 23824297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
    Aspenberg P; Schilcher J; Fahlgren A
    Acta Orthop; 2010 Aug; 81(4):460-2. PubMed ID: 20515438
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
    Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
    Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.